These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29110018)

  • 1. Estimation of Direct Melanoma-related Costs by Disease Stage and by Phase of Diagnosis and Treatment According to Clinical Guidelines.
    Buja A; Sartor G; Scioni M; Vecchiato A; Bolzan M; Rebba V; Sileni VC; Palozzo AC; Montesco M; Del Fiore P; Baldo V; Rossi CR
    Acta Derm Venereol; 2018 Feb; 98(2):218-224. PubMed ID: 29110018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirming the timing of phase-based costing in oncology studies: a case example in advanced melanoma.
    Atkins M; Coutinho AD; Nunna S; Gupte-Singh K; Eaddy M
    J Med Econ; 2018 Feb; 21(2):212-217. PubMed ID: 29022427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of Cutaneous Melanoma by Tumor Stage: A Descriptive Analysis.
    Serra-Arbeloa P; Rabines-Juárez ÁO; Álvarez-Ruiz MS; Guillén-Grima F
    Actas Dermosifiliogr; 2017 Apr; 108(3):229-236. PubMed ID: 27887672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
    Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
    Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
    Alexandrescu DT
    Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality management of cutaneous melanoma: impact on short-term outcomes and costs.
    Buja A; De Luca G; Zorzi M; Carpin E; Pinato C; Vecchiato A; Del Fiore P; Bortolami A; Tognazzo S; Falasco F; Saia M; Baldo V; Rugge M; Rossi CR; Mocellin S
    Eur J Dermatol; 2021 Dec; 31(6):730-735. PubMed ID: 34789442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An estimate of the annual direct cost of treating cutaneous melanoma.
    Tsao H; Rogers GS; Sober AJ
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):669-80. PubMed ID: 9591809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of direct costs of melanoma in the Veneto Region: a budget assessment and cost-consequence analysis.
    Buja A; Sartor G; Scioni M; Girardi G; Vecchiato A; Bolzan M; Rebba V; Chiarion Sileni V; Palozzo AC; Montesco M; Del Fiore P; Baldo V; Rossi CR
    G Ital Dermatol Venereol; 2020 Dec; 155(6):764-771. PubMed ID: 30428652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Outcomes and Direct Healthcare Costs in Patients with Melanoma: Associations with Level of Education.
    Buja A; Rivera M; Zorzi M; Sperotto M; Baracco S; Italiano I; Vecchiato A; Del Fiore P; Avossa F; Corti MC; Guzzinati S; Saia M; Baldo V; Rugge M; Rossi CR
    Acta Derm Venereol; 2020 Jan; 100(1):adv00003. PubMed ID: 31580466
    [No Abstract]   [Full Text] [Related]  

  • 10. Melanoma treatment costs: a systematic review of the literature, 1990-2011.
    Guy GP; Ekwueme DU; Tangka FK; Richardson LC
    Am J Prev Med; 2012 Nov; 43(5):537-45. PubMed ID: 23079178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An estimate of the cost of treating melanoma disease in the state of Sao Paulo - Brazil.
    Souza RJ; Mattedi AP; Rezende ML; Corrêa Mde P; Duarte EM
    An Bras Dermatol; 2009 Jul; 84(3):237-43. PubMed ID: 19668936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study.
    Livingstone E; Krajewski C; Eigentler TK; Windemuth-Kieselbach C; Benson S; Elsenbruch S; Hauschild A; Rompel R; Meiss F; Mauerer A; Kähler KC; Dippel E; Möllenhoff K; Kilian K; Mohr P; Utikal J; Schadendorf D
    Eur J Cancer; 2015 Mar; 51(5):653-67. PubMed ID: 25638778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage-specific direct health care costs in patients with cutaneous malignant melanoma.
    Lyth J; Carstensen J; Synnerstad I; Lindholm C
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):789-93. PubMed ID: 25807966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis.
    Elliott TM; Whiteman DC; Olsen CM; Gordon LG
    Appl Health Econ Health Policy; 2017 Dec; 15(6):805-816. PubMed ID: 28756584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
    Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
    Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous melanoma: cost of illness under Brazilian health system perspectives.
    da Veiga CRP; da Veiga CP; Souza A; Wainstein AJA; de Melo AC; Drummond-Lage AP
    BMC Health Serv Res; 2021 Mar; 21(1):284. PubMed ID: 33781270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study).
    McArthur GA; Mohr P; Ascierto PA; Arance A; Banos Hernaez A; Kaskel P; Weichenthal M; Shinde R; Stevinson K
    Oncologist; 2017 Aug; 22(8):951-962. PubMed ID: 28526721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study.
    Barni S; Maiello E; Di Maio M; Ardizzoni A; Cappuzzo F; Maranzano E; Novello S; Bennati C; Ori A; Rizzoli S; Crinò L;
    Lung Cancer; 2015 Nov; 90(2):234-42. PubMed ID: 26314614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of therapies for melanoma.
    Johnston KM; McPherson E; Osenenko K; Vergidis J; Levy AR; Peacock S
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):229-42. PubMed ID: 25703441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-of-illness of melanoma in Europe - a modelling approach.
    Krensel M; Schäfer I; Augustin M
    J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():34-45. PubMed ID: 30811699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.